Actavis was a generics giant whose rise mirrors the huge growth of off-patent medicines, while Gilead has rocketed into pharma's top 20 ... as by the time products gain FDA approval, 56 per ...

In the first part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Amanda Salindong, associate director of channel & distribution at Alnylam Pharmaceuticals, explains the premise ...

Search for a state or federal candidate to see the donors and industries that support them.

We assign Teva a Morningstar Uncertainty Rating of High, which largely reflects our quantitative analysis of the firm, based on the return ranges used by our star rating system, as well as our ...

Jan. 29, 2025 — Study finds three new safe and effective drug regimens to fight multidrug-resistant TB. The treatments, which include recently discovered TB drugs, give new options for shorter ...

After hours: February 4 at 5:50:20 PM EST Loading Chart for ALNY ...

After hours: February 3 at 5:50:28 PM EST Loading Chart for JAZZ ...